跳至主要内容
临床试验/NCT05038423
NCT05038423已完成不适用

The 5R Shared Leadership Program in Older Adult Walking Groups: A Clustered Randomised Controlled Trial

KU Leuven2 个研究点 分布在 1 个国家目标入组 503 人开始时间: 2018年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
KU Leuven
入组人数
503
试验地点
2
主要终点
Identity leadership

研究概览

简要总结

To test the efficacy of the 5R Shared Leadership program in older adults on participants' identification with their walking group, group cohesion, walking activity, and well-being, compared to a regular group walking program, the investigators conducted a cluster randomised trial.

详细描述

All walking groups participated in a 12-week structured group walking program. Half of these walking groups were randomly assigned to the intervention condition and received additionally the 5R Shared Leadership Program

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Being part of a community-based OKRA SPORT+ meeting point that engages in the 12-week walking program

排除标准

  • 未提供

结局指标

主要结局

Identity leadership

时间窗: 12 weeks

4-item Identity Leadership Inventory-Short Form

Group identification scale

时间窗: 12 weeks

To assess participants' identification with their walking group, the investigators use the 4-item group identification measure (e.g., "I am glad to be a member of this walking group."), as suggested by Doosje et al. (1995). The cognitive, evaluative, and affective aspects of identification are evaluated on a 7-point Likert scale ranging from 1 (strongly disagree) to 7 (strongly agree). Doosje B, Ellemers N, Spears R. Perceived intragroup variability as a function of group status and identification. J Exp Soc Psychol. 1995;31(5):410-36.

次要结局

  • Group cohesion(12 weeks)
  • Walking activity(12 weeks)
  • Well-being(12 weeks)

研究者

发起方
KU Leuven
申办方类型
Other
责任方
Principal Investigator
主要研究者

Katrien Fransen

Associate professor

KU Leuven

研究点 (2)

Loading locations...

相似试验

The 5R Shared Leadership Program in Older Adult... | 临床试验